1 Department of Neurology, Hospital Universitari i Politècnic La Fe, Avd. Fernando Abril Martorell no. 106, 46026 Valencia, Spain 2 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), c/ Eduardo Primo Yúfera no. 13, 46012 Valencia, Spain 3 Department of Medicine, University of Valencia, Avd. Blasco Ibáñez no. 15, 46010 Valencia, Spain.
2 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), c/ Eduardo Primo Yúfera no. 13, 46012 Valencia, Spain 4 Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe (CIPF), c/ Eduardo Primo Yúfera no. 13, 46012 Valencia, Spain
Brain. 2016 Jan;139(Pt 1):62-72. doi: 10.1093/brain/awv311. Epub 2015 Oct 24.
Charcot-Marie-Tooth disease (CMT) is a complex disorder with wide genetic heterogeneity. Here we present a new axonal Charcot-Marie-Tooth disease form, associated with the gene microrchidia family CW-type zinc finger 2 (MORC2). Whole-exome sequencing in a family with autosomal dominant segregation identified the novel MORC2 p.R190W change in four patients. Further mutational screening in our axonal Charcot-Marie-Tooth disease clinical series detected two additional sporadic cases, one patient who also carried the same MORC2 p.R190W mutation and another patient that harboured a MORC2 p.S25L mutation. Genetic and in silico studies strongly supported the pathogenicity of these sequence variants. The phenotype was variable and included patients with congenital or infantile onset, as well as others whose symptoms started in the second decade. The patients with early onset developed a spinal muscular atrophy-like picture, whereas in the later onset cases, the initial symptoms were cramps, distal weakness and sensory impairment. Weakness and atrophy progressed in a random and asymmetric fashion and involved limb girdle muscles, leading to a severe incapacity in adulthood. Sensory loss was always prominent and proportional to disease severity. Electrophysiological studies were consistent with an asymmetric axonal motor and sensory neuropathy, while fasciculations and myokymia were recorded rather frequently by needle electromyography. Sural nerve biopsy revealed pronounced multifocal depletion of myelinated fibres with some regenerative clusters and occasional small onion bulbs. Morc2 is expressed in both axons and Schwann cells of mouse peripheral nerve. Different roles in biological processes have been described for MORC2. As the silencing of Charcot-Marie-Tooth disease genes have been associated with DNA damage response, it is tempting to speculate that a deregulation of this pathway may be linked to the axonal degeneration observed in MORC2 neuropathy, thus adding a new pathogenic mechanism to the long list of causes of Charcot-Marie-Tooth disease.
遗传性运动感觉神经病(Charcot-Marie-Tooth disease,CMT)是一种具有广泛遗传异质性的复杂疾病。本文报道了一种新的轴索性遗传性运动感觉神经病,与微视盘家族 CW 型锌指蛋白 2(MORC2)基因相关。一个常染色体显性遗传家系的全外显子组测序发现了 4 位患者的 MORC2 p.R190W 新突变。在我们的轴索性遗传性运动感觉神经病临床系列中进一步的突变筛查检测到另外 2 例散发性病例,1 例患者携带相同的 MORC2 p.R190W 突变,另 1 例患者携带 MORC2 p.S25L 突变。遗传和计算机模拟研究强烈支持这些序列变异的致病性。表型多变,包括先天性或婴儿期起病的患者,以及 20 岁以后起病的患者。早发性起病的患者表现出类似于脊髓性肌萎缩的表现,而晚发性起病的患者的初始症状为痉挛、远端肌无力和感觉障碍。肌无力和萎缩呈随机和不对称进展,累及肢体带肌,导致成年后严重失能。感觉缺失始终明显,与疾病严重程度成正比。电生理学研究符合不对称性轴索性运动和感觉神经病,而肌束震颤和肌纤维颤动在肌电图检查中记录较为频繁。腓肠神经活检显示出明显的多发性髓鞘纤维缺失,伴有一些再生簇和偶尔的小洋葱球。MORC2 在小鼠周围神经的轴突和施万细胞中均有表达。已有研究描述了 MORC2 在不同生物过程中的作用。由于 Charcot-Marie-Tooth disease 基因的沉默与 DNA 损伤反应有关,因此可以推测该途径的失调可能与在 MORC2 神经病中观察到的轴索变性有关,从而为 Charcot-Marie-Tooth disease 的众多病因增加了一种新的发病机制。